⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 27, 2016The World Journal of Biological Psychiatry

Comments on Cooper et al.’s review on strategies to mitigate dissociative and psychotomimetic effects from ketamine when used as a fast-acting antidepressant

Paul Glue Colleen Loo Anthony Rodgers Verònica Gálvez Andrew A. Somogyi Philip B. Mitchell

View at Publisher

Ask AI

Bookmark

Share

Abstract

"Comments on Cooper et al.’s review on strategies to mitigate dissociative and psychotomimetic effects from ketamine when used as a fast-acting antidepressant." The World Journal of Biological Psychiatry, 18(6), p. 489

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Glue et al. (2016) studied this question.

synapsesocial.com/papers/6a75eff420e137e1c1163224 https://doi.org/10.1080/15622975.2016.1181782

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Two Case Studies of Patients with Major Depressive Disorder Given Low-Dose (Subanesthetic) Ketamine InfusionsOriginal Research · 2006 · 74 citations
2Pilot dose–response trial of i.v. ketamine in treatment-resistant depressionRCT · 2014 · 109 citations
3Placebo‐controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depressionRCT · 2016 · 257 citations
4Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-AnalysisMeta-Analysis · 2015 · 227 citations
5Combating of hippocampal neuroinflammatory response by folic acid: helpful prospective in autistic-like phenotype induced following maternal separation stressThe World Journal of Biological Psychiatry · Wed,

More from The World Journal of Biological Psychiatry

Circulating cell-free DNA and NETosis-related biomarkers in schizophrenia: association with clinical features and treatmentMon,
Metabolomic correlates of intravenous racemic ketamine in treatment-resistant major depressive disorder: the Bio-K/NNDC multicenter trialSun,
Resveratrol in depression: mechanistic networks, preclinical evidence and translational perspectivesFri,
Advances in non-invasive brain stimulation for borderline personality disorder: clinical targets and future directions – an updated narrative reviewSat,
Divergent neurobehavioral signatures of anxiety and depression: a multilevel comparative analysis in adult zebrafishThu,